Hosted on MSN10d
Boston Scientific sees success in PFA device trialUS healthtech giant Boston Scientific’s pulmonary vein isolation (PVI) device trial has met its primary endpoint in patients ...
US healthtech giant Boston Scientific’s pulmonary vein isolation (PVI) device trial has met its primary endpoint in patients with paroxysmal atrial fibrillation (AF) as the company looks to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback